Inventor · disambiguated record
Zhengbin Yao
Also filed as: YAO ZHENGBIN
21 granted patents·18 pending applications·564 citations·filing 1995–2023
96Inventor score
Top patents by PatentIndex Score
39 records- 0197US8753625B2Use of complement inhibitors to treat ocular diseasesFUNG SEK CHUNG·Filed 2006·Granted Jun 17, 2014·62 cites·38 claims
- 0295US6680057B1Methods of treating autoimmune disease by administering interleukin-17 receptorIMMUNEX CORP·Filed 2000·Granted Jan 20, 2004·43 cites·22 claims
- 0394US7994285B2Anti-Notch3 antibodiesGENENTECH INC·Filed 2007·Granted Aug 9, 2011·19 cites·9 claims
- 0494US5869286AReceptor that binds IL-17IMMUNEX CORP·Filed 1996·Granted Feb 9, 1999·81 cites·12 claims
- 0592US6072033AReceptor that binds IL-17IMMUNEX CORP·Filed 1998·Granted Jun 6, 2000·63 cites·8 claims
- 0691US6072037AAntibodies to the IL-17 receptorIMMUNEX CORP·Filed 1998·Granted Jun 6, 2000·60 cites·6 claims
- 0789US6100235AMethods of treating immune and inflammatory response with IL-17 receptorsIMMUNEX CORP·Filed 1998·Granted Aug 8, 2000·48 cites·5 claims
- 0888US6197525B1Assay kits for detection and methods of inhibiting IL-17 bindingIMMUNEX CORP·Filed 1998·Granted Mar 6, 2001·46 cites·4 claims
- 0988US6096305AReceptor that binds IL-17IMMUNEX CORP·Filed 1998·Granted Aug 1, 2000·46 cites·10 claims
- 1085US8513388B2Anti-Notch3 antibodiesLI KANG·Filed 2011·Granted Aug 20, 2013·7 cites·14 claims
- 1184US8956811B2Diagnosis of malignant neoplasms using anti-Notch3 antibodiesGENENTECH INC·Filed 2013·Granted Feb 17, 2015·6 cites·16 claims
- 1284US8841994B2Intelligent traffic safety system based on comprehensive state detection and decision method thereofBEIJING ITS STAR TECHNOLOGY CO LTD·Filed 2012·Granted Sep 23, 2014·20 cites·19 claims
- 1383US9873734B2Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseasesGENENTECH INC·Filed 2012·Granted Jan 23, 2018·4 cites·5 claims
- 1483US7754678B2Membrane penetrating peptides and uses thereofAVENTIS PHARMA INC·Filed 2005·Granted Jul 13, 2010·8 cites·12 claims
- 1583US7432237B2Methods of treating asthma by administering interleukin-17 receptorIMMUNEX CORP·Filed 2003·Granted Oct 7, 2008·9 cites·16 claims
- 1680US7273843B2Methods of treating allergy by administering interleukin-17 receptorIMMUNEX CORP·Filed 2003·Granted Sep 25, 2007·7 cites·18 claims
- 1780US6555328B1Screening methods for altering circadian rhythms and for human casein kinase I δ and/or ε phosphorylation of human clock proteins, period 1, -2 and -3AVENTIS PHARMA INC·Filed 2000·Granted Apr 29, 2003·24 cites·57 claims
- 1868US2010173383A1Nuclear Factor Of Activated T Cells ReceptorGENENTECH INC·Filed 2009·Application pending·0 cites
- 1966US2009068737A1Methods of inhibiting interleukin-17 receptorIMMUNEX CORP·Filed 2007·Application pending·0 cites
- 2064US2023303707A1Anti-pad4 autoantibodies as clinical response biomarkers for the treatment of rheumatoid arthritisMEDIMMUNE LTD·Filed 2023·Application pending·0 cites
- 2163US2009022710A1Nuclear factor of activated t cells receptorGENENTECH INC·Filed 2008·Application pending·0 cites
- 2258US2014335078A1Use Of Complement Inhibitors To Treat Ocular DiseasesGENENTECH INC·Filed 2014·Application pending·0 cites
- 2357US2010233186A1Novel receptor that binds ctla-8IMMUNEX CORP·Filed 2010·Application pending·0 cites
- 2456US11613580B2Anti-PAD4 autoantibodies as clinical response biomarkers for the treatment of rheumatoid arthritisMEDIMMUNE LTD·Filed 2017·Granted Mar 28, 2023·0 cites·11 claims
- 2555US2006292668A1Nuclear factor of activated t cell receptorYAO ZHENGBIN·Filed 2003·Application pending·0 cites
- 2655US2018334495A1Use of complement pathway inhibitors to treat ocular diseasesGENENTECH INC·Filed 2017·Application pending·0 cites
- 2753US2011124081A1Nuclear factor of activated t cells receptorGENENTECH INC·Filed 2010·Application pending·0 cites
- 2846US5716623AIsolated Herpesvirus saimiri proteins that bind MHC Class II moleculesIMMUNEX CORP·Filed 1995·Granted Feb 10, 1998·11 cites·10 claims
- 2946US2004033226A1Osteopontin, oligodendrocytes and myelinationAVENTIS PHARMA INC·Filed 2003·Application pending·0 cites
- 3046US2009156467A1Thymic stromal lymphpoietin promoter and use thereforYAO ZHENGBIN·Filed 2005·Application pending·0 cites
- 3145US2003147887A1B-cell lymphoma specific antigen for use in diagnosis and treatment of B-cell malignanciesFiled 2002·Application pending·0 cites
- 3242US2008267973A1Diagnosis and Treatment of Siglec-6 Associated DiseasesGENENTECH INC·Filed 2005·Application pending·0 cites
- 3342US2003229202A1Membrane penetrating peptides and uses thereofFiled 2001·Application pending·0 cites
- 3441US2007128667A1Secreted neural apoptosis inhibiting proteinsAVENTIS PHARMA INC·Filed 2004·Application pending·0 cites
- 3540US2005288487A1Human mast cell-expressed membrane proteinsLI KANG·Filed 2003·Application pending·0 cites
- 3638US2019305348A1Method, Device and System for Controlling Fuel Cell and Rail VehicleCRRC QINGDAO SIFANG CO LTD·Filed 2017·Application pending·0 cites
- 3734US2007260042A1Human mast cell-expressed membrane protein (gpcr)LI KANG·Filed 2004·Application pending·0 cites
- 3827US11706097B2Task processing method applied to network topology, electronic device and storage mediumNOVNET COMPUTING SYSTEM TECH CO LTD·Filed 2021·Granted Jul 18, 2023·0 cites·8 claims
- 3926US11706076B2Computer system with computing devices, communication device, task processing deviceNOVNET COMPUTING SYSTEM TECH CO LTD·Filed 2021·Granted Jul 18, 2023·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Zhengbin Yao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →